GARFIELD-AF: risk profiles, treatment patterns and 2-year
outcomes in patients with atrial fibrillation in Germany,
Austria and Switzerland (DACH) compared to 32 countries in
other regions worldwide

J 2023

GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

HAAS, Sylvia; John A CAMM; Darius HARALD; Jan STEFFEL; Saverio VIRDONE et al.

Základní údaje

Originální název

GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

Autoři

HAAS, Sylvia; John A CAMM; Darius HARALD; Jan STEFFEL; Saverio VIRDONE; Karen PIEPER; Marianne BRODMANN; Sebastian SCHELLONG; Frank MISSELWITZ; Gloria KAYANI a Ajay K KAKKAR

Vydání

Clinical Research in Cardiology, Heidelberg, Springer, 2023, 1861-0684

Další údaje

Typ výsledku

Článek v odborném periodiku

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 3.800

Označené pro přenos do RIV

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

Atrial fibrillation; GARFIELD-AF; Oral anticoagulation; Non-vitamin K antagonist oral anticoagulants; Vitamin K antagonists; Phenprocoumon

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 14. 4. 2026 15:52, Mgr. Petra Trembecká, Ph.D.

Citovat

HAAS, Sylvia; John A CAMM; Darius HARALD; Jan STEFFEL; Saverio VIRDONE; Karen PIEPER; Marianne BRODMANN; Sebastian SCHELLONG; Frank MISSELWITZ; Gloria KAYANI a Ajay K KAKKAR. GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide. Clinical Research in Cardiology. Heidelberg: Springer, 2023. ISSN 1861-0684. Dostupné z: https://doi.org/10.1007/s00392-022-02079-y.

@article{2265038,
   author = {Haas, Sylvia and Camm, John A and Harald, Darius and Steffel, Jan and Virdone, Saverio and Pieper, Karen and Brodmann, Marianne and Schellong, Sebastian and Misselwitz, Frank and Kayani, Gloria and Kakkar, Ajay K},
   article_location = {Heidelberg},
   doi = {https://doi.org/10.1007/s00392-022-02079-y},
   keywords = {Atrial fibrillation; GARFIELD-AF; Oral anticoagulation; Non-vitamin K antagonist oral anticoagulants; Vitamin K antagonists; Phenprocoumon},
   issn = {1861-0684},
   journal = {Clinical Research in Cardiology},
   title = {GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide},
   year = {2023}
}

TY  - JOUR
ID  - 2265038
AU  - Haas, Sylvia - Camm, John A - Harald, Darius - Steffel, Jan - Virdone, Saverio - Pieper, Karen - Brodmann, Marianne - Schellong, Sebastian - Misselwitz, Frank - Kayani, Gloria - Kakkar, Ajay K
PY  - 2023
TI  - GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide
JF  - Clinical Research in Cardiology
PB  - Springer
SN  - 18610684
KW  - Atrial fibrillation
KW  - GARFIELD-AF
KW  - Oral anticoagulation
KW  - Non-vitamin K antagonist oral anticoagulants
KW  - Vitamin K antagonists
KW  - Phenprocoumon
ER  -

HAAS, Sylvia; John A CAMM; Darius HARALD; Jan STEFFEL; Saverio VIRDONE; Karen PIEPER; Marianne BRODMANN; Sebastian SCHELLONG; Frank MISSELWITZ; Gloria KAYANI a Ajay K KAKKAR. GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide. \textit{Clinical Research in Cardiology}. Heidelberg: Springer, 2023. ISSN~1861-0684. Dostupné z: https://doi.org/10.1007/s00392-022-02079-y.

Přehled o publikaci